Skip to content

TuHURA Biosciences, Inc.

HURA· NasdaqCore metricsCIK 1498382

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -5.30%
Market cap
$94.03M
65.76M shares
Filings
931
$0.00
Q1 2026
-$6.41M
Q3 2026N/M FY25 yoy
-$3.25K
Q2 2013N/M FY12 yoy
-$18.24M
Q3 2026derivedN/M FY25 yoy
-$0.10
Q3 2026N/M FY25 yoy
$1.89M
Q3 2026−71.4% FY25 yoy
$94.03M
—
—
5.0×
-29.46%
—

FY2025 figures · derived

Price

$1.4339.92%$0.95past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$0.000FY 2011FY 2012FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20122012-06-30$0reported
FY 20112011-06-30$0reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$24.75K$24.75K—12.17M sh−84.9%—

Pharmaceutical preparations

TuHURA Biosciences, Inc. is the 292nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR